Stock screenerAll disclosures →
EDGAR →
RXST
Conviction 8HealthcareScan · Thu, Sep 24, 2026RxSight, Inc. (RXST) closed at $4.74 (-2.27%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 13, -63.8% from its 52-week high, -54.3% year to date. Sector: Healthcare · OPHTHALMIC GOODS.
RXST$4.74-2.27%
ResistanceSupportVol 14Insider sell4
Vol MA14 790.83K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price4.74
Change-2.27%
Gap-0.41%
Rel volume1.42×
Avg volume798.89K
Avg $ vol4.79M
SMA 206.00
SMA 506.08
SMA 2007.20
Price vs 50-22.03%
Price vs 200-34.19%
MA stackbearish
50/200 cross—
Supertrenddown · 5.71
RSI (14)27
MACD hist-0.17
MACD cross—
Stoch %K / %D3 / 2
ADX (14)22
+DI / −DI15 / 38
RSI divergenceBearish
MACD divergenceBearish
ATR %7.10%
ADR %5.80%
52w high13.09
52w low4.59
From 52w high-63.79%
Above 52w low+3.27%
New 52w highNo
SqueezeOff
Bollinger width52.59%
%B0.10
Donchian pos2.35%
Donchian high7.44
Donchian low4.68
AVWAP (52w high)6.97
vs AVWAP high-31.97%
AVWAP (52w low)5.65
vs AVWAP low-16.09%
OBV trendDown
Chaikin MF (20)-0.22
Today vs 20d1.42×
Avg vol (14d)790.83K
Avg vol (20d)798.89K
Avg $ vol (20d)4.79M
Market cap197.15M
RS Rating13 / 99
RS 3m (vs SPY)-12.09%
RS 6m (vs SPY)-44.89%
RS line new highNo
Trend template0/8
Technical rank9.1
1 week-10.90%
1 month-25.94%
3 months-7.60%
6 months-28.07%
1 year-49.89%
YTD-54.34%
P/E-5.06
P/B0.75
P/S1.47
P/FCF-10.19
EPS-0.9500
Div yield—
ROE-14.79%
ROA-11.04%
Debt/Eq0.00
Current4.07
EV/EBITDA-4.09
Gross margin76.60%
Net margin-28.96%
Rev growth-3.89%
EPS growth-41.85%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value183.8M
Revenue27.24M
Net income-12.1M
Gross profit23.5M
Free cash flow-19.34M
IndustryOPHTHALMIC GOODS
ExchangeNasdaq
Shares out41.4M
Employees461
ListedFri, Jul 30, 2021
Free float37.79M
Float %91.9%
Short interest3.88M
Days to cover4.6d
Short volume34.9%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank9.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.33
Support5.69
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RXST
No recent disclosed trades by Congress in RXST. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RXST
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kurtz Ronald M MD Chief Medical Officer · Stock option (right to buy) · 2026-09-05 | Disposition | 338.82K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Disposition | 120K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Disposition | 92.2K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Disposition | 50K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Disposition | 125K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Grant | 73.96K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Grant | 104.35K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Grant | 59.48K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Grant | 32.26K | — | 2026-09-05 | 2026-09-09 |
Goldshleger Ilya Chief Operating Officer · Stock Option (right to buy) · 2026-09-05 | Grant | 93.98K | — | 2026-09-05 | 2026-09-09 |
SEC filings
EDGAR filings in RXST · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.